Plus TherapeuticsCNSY
13F holders, Q2 2025 (June 30)19holders +2
8new positions
6sold out
1famous investor
$0.35avg. 13F price*
At the end of Q2 2025, 19 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, up 2 from Q1 2025. 8 opened new positions and 6 sold out. The largest holders were Jane Street Group, LLC ($41K), UBS Group AG ($30K) and Geode Capital Management, LLC ($18K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $63K |
| Exits | 6 | $224K |
All 13F filers, Q1 2025 → Q2 2025: 236,055 shares bought and 247,005 shares sold, net −10,950 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Jane Street Group, LLC | 0.00% | New | 117,454 | $41K |
| UBS Group AG | 0.00% | Add +162.1% | 87,638 | $30K |
| Geode Capital Management, LLC | 0.00% | Reduce -10.3% | 51,176 | $18K |
| Vanguard Group Inc. | 0.00% | No change | 32,541 | $11K |
| Goldman Sachs Group Inc. | 0.00% | New | 26,753 | $9K |
| Millennium Management | 0.00% | New | 24,233 | $8K |
| Ground Swell Capital, LLC | 0.01% | Reduce -16.1% | 11,453 | $4K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 10,223 | $4K |
| BlackRock, Inc. | 0.00% | No change | 6,960 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -21.3% | 6,045 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +775.2% | 2,258 | $785 |
| Atlantic Union Bankshares Corp | 0.00% | New | 500 | $174 |
| Wells Fargo & Company | 0.00% | New | 357 | $124 |
| Tradewinds Capital Management, LLC | 0.00% | New | 200 | $70 |
| Bank of America Corp. | 0.00% | Add +216.0% | 158 | $55 |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $45 |
| Barclays PLC | 0.00% | Reduce -90.2% | 102 | $36 |
| Jones Financial Companies LLLP | 0.00% | New | 26 | $8 |
| Danske Bank A/S | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.